Evidence map›Paper›PMID 39982127›Full record

ArticleBiomacromolecules2025

Synthesis and Characterization of λ-Carrageenan Oligosaccharide-Based Nanoparticles: Applications in MRI and In Vivo Biodistribution Studies.

Manon Porta-Zapata, Susana Carregal-Romero, Jennifer Saliba, Ainhize Urkola-Arsuaga, Claudia Beatriz Miranda Perez de Alejo, Iñaki Orue, Lydia Martínez-Parra, Desirè Di Silvio, Armel Descamps-Mandine, Clément Daviaud and 11 more

Abstract read
In one paragraph

Article in Biomacromolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Manon Porta-ZapataLaboratoire LIENSs, UMR CNRS 7266─La Rochelle Université, 17000 La Rochelle, France.
Susana Carregal-RomeroCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia, Spain.ORCID 0000-0003-1444-6268
Jennifer SalibaLaboratoire LIENSs, UMR CNRS 7266─La Rochelle Université, 17000 La Rochelle, France.
Ainhize Urkola-ArsuagaCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia, Spain.
Claudia Beatriz Miranda Perez de AlejoCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia, Spain.
Iñaki OrueSGIker Medidas Magnéticas, 48940 Leioa, Spain.ORCID 0000-0002-7496-2566
Lydia Martínez-ParraCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia, Spain.
Desirè Di SilvioCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia, Spain.
Armel Descamps-MandineCentre de Micro-Caractérisation Raimond Castaing, UAR3623, 31400 Toulouse, France.
Clément DaviaudLaboratoire LIENSs, UMR CNRS 7266─La Rochelle Université, 17000 La Rochelle, France.
Maelenn MenardLaboratoire LIENSs, UMR CNRS 7266─La Rochelle Université, 17000 La Rochelle, France.
Ameur HamamiLaSIE, UMR CNRS 7356─Université de La Rochelle, 17042 La Rochelle, France.
Benjamin MusnierLaboratoire LIENSs, UMR CNRS 7266─La Rochelle Université, 17000 La Rochelle, France.
Julien CherfanLaboratoire LIENSs, UMR CNRS 7266─La Rochelle Université, 17000 La Rochelle, France.
Axel CodaultLaboratoire LIENSs, UMR CNRS 7266─La Rochelle Université, 17000 La Rochelle, France.
Chanez ManseurLaboratoire LIENSs, UMR CNRS 7266─La Rochelle Université, 17000 La Rochelle, France.
Marc JeanninLaSIE, UMR CNRS 7356─Université de La Rochelle, 17042 La Rochelle, France.
David CastejónICTS Bioimagen Complutense (BIOIMAC), Madrid 28040, Spain.
Ingrid Fruitier-ArnaudinLaboratoire LIENSs, UMR CNRS 7266─La Rochelle Université, 17000 La Rochelle, France.
Jesús Ruiz-CabelloCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia, Spain.ORCID 0000-0001-8681-5056
Hugo GroultLaboratoire LIENSs, UMR CNRS 7266─La Rochelle Université, 17000 La Rochelle, France.ORCID 0000-0002-1571-9400

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

λ-type carrageenan (λ-CAR) polysaccharides remain overlooked in the preparation of medical nanoparticles (NP) due to their unsuitable rheological properties and undesired biological effects, although they can also offer advantageous properties. To overcome these obstacles, oligosaccharide derivatives (λ-COS) have been successfully applied to the synthesis of stable NP incorporating both, ferrite cores and divalent manganese (Mn

Indexed as

CarrageenanNanoparticlesAnimalsCell LineFemaleHumansMagnetic Resonance SpectroscopyMagneticsManganeseMiceMice, Inbred BALB CSpectroscopy, Fourier Transform InfraredCarrageenanManganese

Identifiers

PMID39982127
PMCPMC11900770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.